Autoimmune thyroid disease frequently coexists with metabolic syndrome, a cluster of conditions including obesity, insulin resistance, dyslipidemia, and fatty liver disease
You start at the lowest dose (.25mg), you lose 6 pounds and then you plateau, then you go to .5mg, lose some more, then 1mg, then 1.5, and on up to 2mg

In terms of safety and tolerability, the adverse events were primarily mild to moderate gastrointestinal reactions, with no reports of severe hypoglycemia or death.161 In summary, dual and triple agonists related to GLP-1 represent significant advances in the field of diabetes treatment,167,168 demonstrating the future trend of enhancing therapeutic effects by targeting multiple biomarkers.136,169,170 With the accumulation of more clinical data and the development of new drugs, these treatment options are expected to provide more effective and comprehensive treatment choices for diabetes patients.161,167 GLP-1 .124,125,126 , , .43 , .127,128 GLP-1R .124,129 GLP-1 GIP .130 , ( Mounjaro) GLP-1 GIPR .124 GLP-1 .131,132,133 , GLP-1 .121,134 GIP , GLP-1 .125,130 2022, 2 FDA .135,136 , .135 , T2DM .136,137,138 , .139,140,141 , .141 , .141,142 3 , , 7 77 .143 2 , .143 , 2

Furthermore, it reduces the amount of sugar released by your liver and slows the rate at which food leaves your stomach to help prevent spikes in blood sugar
doi: 10.1016/j.molmet.2018.09.009 58 RetnakaranRZinmanB
Whats most important is you are well set up to make healthy choices and lifestyle changes that work best for you